✦ LIBER ✦

PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

✍ Scribed by F. Navarro sarabia; F.J. Blanco; J. Álvaro-Gracia; J. García Meijide; J. Poveda; E. Ruiz-beato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparing Costs Per Clinical Remission o

✍ Buschinelli, C.T.; Tsuchiya, C.T.; Maximo, M.F.M.; Tobaruella, F.S.; Gonçalves, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Comparison of tocilizumab monotherapy ve

✍ Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D 📂 Article 📅 2009 🏛 BMJ Publishing Group 🌐 English ⚖ 332 KB

Analyzing Costs Per Clinical Remission o

✍ Buschinelli, C.T.; Maximo, M.F.M.; Tsuchiya, C.T.; Tobaruella, F.S.; Gonçalves, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Clinical efficacy of abatacept compared

✍ Takahashi, Nobunori; Kojima, Toshihisa; Kaneko, Atsushi; Kida, Daihei; Hirano, Y 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 364 KB

Effects of adalimumab monotherapy versus

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy and safety of adalimumab as mon

✍ van de Putte, L B A 📂 Article 📅 2004 🏛 BMJ Publishing Group 🌐 English ⚖ 457 KB